Csenge Advisory Group’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-5,395
Closed -$260K 692
2025
Q2
$260K Sell
5,395
-3,297
-38% -$162K 0.01% 584
2025
Q1
$428K Sell
8,692
-1,187
-12% -$69.2K 0.02% 434
2024
Q4
$559K Sell
9,879
-90
-0.9% -$5.03K 0.03% 397
2024
Q3
$520K Buy
+9,969
New +$468K 0.03% 409
2024
Q2
Sell
-9,484
Closed -$514K 674
2024
Q1
$514K Buy
9,484
+1,018
+12% +$51.9K 0.03% 423
2023
Q4
$434K Sell
8,466
-2,676
-24% -$140K 0.03% 435
2023
Q3
$647K Sell
11,142
-251
-2% -$15.4K 0.04% 305
2023
Q2
$729K Buy
11,393
+794
+7% +$53.2K 0.05% 283
2023
Q1
$735K Buy
10,599
+2,988
+39% +$211K 0.05% 265
2022
Q4
$548K Buy
7,611
+197
+3% +$14.9K 0.04% 326
2022
Q3
$527K Sell
7,414
-2,192
-23% -$159K 0.04% 327
2022
Q2
$740K Buy
9,606
+1,172
+14% +$89.3K 0.06% 267
2022
Q1
$616K Sell
8,434
-1,604
-16% -$108K 0.05% 326
2021
Q4
$668K Buy
10,038
+4,851
+94% +$285K 0.06% 275
2021
Q3
$309K Sell
5,187
-4,851
-48% -$319K 0.03% 462
2021
Q2
$668K Sell
10,038
-2,083
-17% -$136K 0.06% 276
2021
Q1
$759K Sell
12,121
-609
-5% -$37.9K 0.08% 192
2020
Q4
$790K Sell
12,730
-1,029
-7% -$63.3K 0.09% 161
2020
Q3
$794K Sell
13,759
-2,139
-13% -$129K 0.11% 157
2020
Q2
$935K Sell
15,898
-578
-4% -$34.6K 0.13% 122
2020
Q1
$918K Sell
16,476
-419
-2% -$25.6K 0.24% 90
2019
Q4
$1.08M Buy
16,895
+5,626
+50% +$322K 0.28% 75
2019
Q3
$572K Sell
11,269
-4,839
-30% -$227K 0.16% 126
2019
Q2
$742K Sell
16,108
-1,107
-6% -$51.6K 0.25% 71
2019
Q1
$821K Buy
17,215
+6,401
+59% +$319K 0.28% 67
2018
Q4
$562K Buy
10,814
+1,789
+20% +$96.1K 0.21% 89
2018
Q3
$474K Buy
+9,025
New +$536K 0.18% 89

Other funds holding BMY